Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Holistica Hawaii Preventive Medicine was a specialized healthcare facility based in Honolulu, Hawaii, dedicated to early disease detection and wellness. The center was a pioneer in the use of Electron Beam Computed Tomography (EBCT), a high-speed imaging technology used to identify calcium deposits in coronary arteries and early-stage tumors. Beyond diagnostics, the company provided integrated health programs that included personalized nutrition, exercise physiology, and stress management. It was founded by David Watumull, who served as the CEO and later transitioned the company's focus toward biotechnology. The research conducted at Holistica regarding inflammation and C-reactive protein (CRP) served as the foundation for the launch of Cardax, a company developing anti-inflammatory dietary supplements and pharmaceuticals. While the clinic eventually closed its doors to focus on these biotech ventures, it remains a significant part of Hawaii's healthcare history in the preventive medicine sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holistica Hawaii Preventive Medicine.